期刊文献+

左侧心力衰竭相关性肺动脉高压的研究进展 被引量:3

Research Progress in Pulmonary Hypertension Caused by Left Heart Failure
暂未订购
导出
摘要 目前国内外关于左侧心力衰竭相关性肺动脉高压的研究较少,其发病率、病理生理机制和治疗方法尚缺乏有效的数据,而其导致的预后又较差,需加强对此类疾病的认识。鉴于此,现就左侧心力衰竭相关性肺动脉高压的病因(如高血压、缺血性心脏病等)、发病机制(如细胞因素、分子因素等)、临床特点(如危险因素、临床特征等)及治疗方法等(如吸入一氧化氮、依前列醇类药物、内皮素受体拮抗剂、5型磷酸二酯酶抑制剂、干细胞治疗等)的研究进展予以简单的介绍。 The research of pulmonary hypertension caused by left heart failure is lack at present, and there is little valid data for its prevalence, physiopathological mechanism and treatment, moreover, its progno- sis is poor. It is necessary to improve the research of pulmonary hypertension. Here is to make a review of the research progress of pulmonary hypertension caused by left heart failure, such as its etiology( such as hyper- tension, isehemie heart disease etc. ) , pathogenesis (cell factor, molecular factor) , clinical features (such as risk factors, clinical features etc. ) and treatment( such as inhalation of NO, epoprostenol, endothelin receptor antagonists, phosphodiesterase type 5 inhibitors, stem cell therapy, etc. ).
出处 《医学综述》 2013年第11期2002-2005,共4页 Medical Recapitulate
关键词 肺动脉高压 左侧心力衰竭 药物治疗 干细胞治疗 Pulmonary hypertension Left heart failure /)rug therapy Stem cell therapy
  • 相关文献

参考文献21

  • 1Hogg K,Swedberg K,McMurray J.Heart failure with preserved leftventricular systolic function;epidemiology,clinical characteristics,and prognosis[J].J Am Coll Cardiol,2004,43(3):317-327.
  • 2Guazzi M,Arena R.Pulmonary hypertension with left-sided heartdisease[J].Nat Rev Cardiol,2010 7(11):648-659.
  • 3Dadfarmay S,Berkowitz R,Kim B,et al.Differentiating pulmonaryarterial and pulmonary venous hypertension and the implications fortherapy[J].Congest Heart Fail,2010,16(6):287-291.
  • 4Erer B,Eren M.Pulmonary hypertension caused by left heart dis-ease[J].Anadolu Kardiyol Derg,2010,10(Suppl 2):42-46.
  • 5Corte TJ,McDonagh TA,Wort SJ.Pulmonary hypertension in leftheart disease:a review[J].Int J Cardiol,2012,156(3):253-258.
  • 6Guglin M,Khan H.Pulmonary hypertension in heart failure[J].JCard Fail,2010,16(6):461-474.
  • 7Hoffmann J,Yin J,Kukucka M,Yin N,et al.Mast cells promotelung vascular remodeling in pulmonary hypertension[J].EurRespir J,2011,37(6):1400-1410.
  • 8Lindman BR,Chakinala MM.Modulating the nitric oxide-cyclicGMP pathway in the pressure-overloaded left ventricle and groupⅡpulmonary hypertension[J].Int J Clin Pract Suppl,2010,64(168):15-22.
  • 9Dai ZK,Wu BN,Chen IC,et al.Attenuation of pulmonary hyper-tension secondary to left ventricular dysfunction in the rat by Rho-kinase inhibitor fasudil[J].Pdiatr Pulmonol,2011,46(1):45-59.
  • 10Karapinar H,Esen O,Emiroglu Y,et al.Serum levels of angiopoie-tin-1 in patients with pulmonary hypertension due to mitral stenosis[J].Heart Vessels,2011,26(5):536-541.

二级参考文献27

  • 1Hirai H. Stem cells and regenerative medicine [ J ]. Hum Cell,2002,15 (4) :190 - 198.
  • 2Jevon M, Dorling A, Homick PI. Progenitor cells and vascular disease [J]. Cell Prolif,2008,41 ( 1 ): 146 - 164.
  • 3Pountos I, Corscadden D, Emery P, et al. Mesenchymal stem cell tissue engineering:Techniques for isolation, expansion and application [J]. Injury,2007,38(4) :S23-S33.
  • 4Levenberg S, Golub JS, Amit M,et al. Endothelial cells derived from human embryonic stem cells[J]. Proc Natl Acad Sci USA,2002,99(7) : 4391 - 4396
  • 5Yuan X,Zhang H,Wei YJ,et al. Embryonic stem cell transplantation for the treatment of myocardial infarction: Immune privilege or rejection [J]. Transpl Immunol,2007,18(2) :88 -93.
  • 6Kalka C, Masnuda H, Takahashi T, et al. Transplatation of ex vivo expanded endothelial progenitor cells for the therapeutic neovascularization [J]. Proc Natl Acad Sci USA,2000,97(7) :3422 -3427.
  • 7Davie N ,Crossno JT,Frid MG,et al. Hypoxia- induced pulmonary artery adventitial remodeling and neovascularization: Contribution of progenitor cells[ J ]. Am J Physiol Lung Cell Mol Physiol,2004,286( 7 ) :668- 678.
  • 8Noritoshi N, Kenji K, Munetake K,et al. Hybrid cell - gene therapy for pulmonary hypertension based on phagocytosing action of endothelial progenitor cells [ J ]. Circulation,2003,108 ( 10 ) :889 - 895.
  • 9Yidan DZ, David W, Yupu D,et al. Rescue of monocrotaline - induced pulmonary arterial hypertension using bone marrow - derived endothe- lial - like progenitor cells : Efficacy of combined cell and eNOS gene therapy in established disease [ J ]. Circ Res ,2005 ,96 (3) :442 - 450.
  • 10Mitsuru T,Tatsuo N, Tonshinari T, et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs[J]. Tissue Eng,2004,10(5) :771 -779.

共引文献10

同被引文献40

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部